Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Public ClinicalTrials.gov record NCT01962636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for the Treatment of Hematological Diseases
Study identification
- NCT ID
- NCT01962636
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Other
- Enrollment
- 200 participants
Conditions and interventions
Conditions
- Acute Lymphocytic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Burkitt's Lymphoma
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Diffuse Large B Cell Lymphoma
- Follicular Lymphoma
- Lymphoblastic Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle-Cell Lymphoma
- Marginal Zone B-Cell Lymphoma
- Multiple Myeloma
- Myelodysplasia
- Myelofibrosis
- Non-Hodgkin Lymphoma
- Plasma Cell Leukemia
- Prolymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
- Cyclophosphamide Drug
- Cyclosporine A Drug
- Fludarabine Drug
- Mycophenylate mofetil Drug
- Total Body Irradiation Radiation
- Umbilical cord blood Biological
Drug · Radiation · Biological
Eligibility (public fields only)
- Age range
- Up to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2028
- Last update posted
- Mar 11, 2026
2016 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Minnesota Masonic Cancer Center | Minneapolis | Minnesota | 55455 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01962636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01962636 live on ClinicalTrials.gov.